E-LIB Suche - Ergebnisse für: Walewski, Jan

1

Ibrutinib combined with immunochemotherapy with or without ..:

Dreyling, Martin ; Doorduijn, Jeanette ; Giné, Eva...
The Lancet. 403 (2024) 10441 - p. 2293-2306 , 2024

Link: https://doi.org/10.1016/..

2

Prognostic value of coronary atherosclerosis and CAC score ..:

Borowiec, Anna ; Ozdowska, Patrycja ; Rosinska, Magdalena...
PLOS ONE. 18 (2023) 8 - p. e0288146 , 2023

Link: https://doi.org/10.1371/..

3

Pembrolizumab in Relapsed or Refractory Primary Mediastinal..:

Zinzani, Pier Luigi ; Thieblemont, Catherine ; Melnichenko, Vladimir...
Blood Journal. , 2023

Link: https://doi.org/10.1182/..

4

Parsaclisib, a PI3Kδ inhibitor, in relapsed and refractory ..:

Zinzani, Pier Luigi ; Trněný, Marek ; Ribrag, Vincent...
eClinicalMedicine. 62 (2023) - p. 102131 , 2023

Link: https://doi.org/10.1016/..

5

P1115: ODRONEXTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY DI..:

Walewski, Jan ; Min Kim, Tae ; Cho, Seok-Goo...
HemaSphere. 7 (2023) S3 - p. e50570ac , 2023

Link: https://doi.org/10.1097/..

6

Safety and efficacy of induction immunochemotherapy with ri..:

Ostrowska, Beata ; Domanska‐Czyz, Katarzyna ; Romejko‐Jarosinska, Joanna...
British Journal of Haematology. 201 (2023) 4 - p. 663-672 , 2023

Link: https://doi.org/10.1111/..

7

PB2358: PHASE 1-2 STUDY OF THE SAFETY, PK, PD, AND PRELIMIN..:

Shortt, Jake ; Poligone, Brian ; Ribrag, Vincent...
HemaSphere. 7 (2023) S3 - p. e07947e7 , 2023

Link: https://doi.org/10.1097/..

8

New molecular targets in Hodgkin and Reed-Sternberg cells:

Sadaf, Hummaira ; Ambroziak, Maciej ; Binkowski, Robert...
Frontiers in Immunology. 14 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

9

Challenges of oncological care in Poland hosting Ukrainian ..:

Wyrwicz, Lucjan ; Walewski, Jan ; Rutkowski, Piotr
European Journal of Cancer. 178 (2023) - p. 243-244 , 2023

Link: https://doi.org/10.1016/..

10

Early efficacy and safety of obinutuzumab with chemotherapy..:

Paszkiewicz-Kozik, Ewa ; Hus, Iwona ; Palka, Monika...
Advances in Clinical and Experimental Medicine. 32 (2023) 1 - p. 131-136 , 2023

Link: https://doi.org/10.17219..

11

PB2358: PHASE 1-2 STUDY OF THE SAFETY, PK, PD, AND PRELIMIN..:

Jake Shortt ; Brian Poligone ; Vincent Ribrag...
http://journals.lww.com/10.1097/01.HS9.0000976148.07947.e7. , 2023

Link: https://doi.org/10.1097/..

12

New molecular targets in Hodgkin and Reed-Sternberg cells:

Hummaira Sadaf ; Maciej Ambroziak ; Robert Binkowski...
https://www.frontiersin.org/articles/10.3389/fimmu.2023.1155468/full. , 2023

Link: https://doi.org/10.3389/..

13

Carfilzomib, lenalidomide, and dexamethasone or lenalidomid..:

Dytfeld, Dominik ; Wróbel, Tomasz ; Jamroziak, Krzysztof...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10337122/. , 2023

Link: http://www.ncbi.nlm.nih...

14

New molecular targets in Hodgkin and Reed-Sternberg cells:

Sadaf, Hummaira ; Ambroziak, Maciej ; Binkowski, Robert...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230546/. , 2023

Link: http://www.ncbi.nlm.nih...

15

PB2358: PHASE 1-2 STUDY OF THE SAFETY, PK, PD, AND PRELIMIN..:

Shortt, Jake ; Poligone, Brian ; Ribrag, Vincent...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429443/. , 2023

Link: http://www.ncbi.nlm.nih...